Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives
Bruno P. Imbimbo, Madia Lozupone, Mark Watling, et al.
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 9, pp. 919-933
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease
Mengtian Guo, Zhenyu Yin, Fanglian Chen, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 135
Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases
Britney N. Lizama, Jennifer Kahle, Susan M. Catalano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6251-6251
Open Access | Times Cited: 25
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 8
Current druggable targets for therapeutic control of Alzheimer's disease
Girdhari Lal Gupta, Nikita Patil Samant
Contemporary Clinical Trials (2021) Vol. 109, pp. 106549-106549
Closed Access | Times Cited: 33
Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future
Leonard A. Levin, Christopher Patrick, Nozhat Choudry, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 25
Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium
Gabriel A. de Erausquin, Heather M. Snyder, Traolach Brugha, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
Filomena Lo Vecchio, Paola Bisceglia, Bruno P. Imbimbo, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13
Open Access | Times Cited: 20
Transcriptomic and epigenomic landscapes of Alzheimer's disease evidence mitochondrial-related pathways
Alejandro Marmolejo-Garza, Tiago Medeiros-Furquim, Ramya Rao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 10, pp. 119326-119326
Open Access | Times Cited: 20
Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism
Jiwei Jiang, Hanping Shi, Shirui Jiang, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 10, pp. 2257-2279
Open Access | Times Cited: 11
Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles
Sara Tucker Edmister, Thaís Del Rosario Hernández, Rahma Ibrahim, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Therapeutic potential of extracellular vesicles in neurodegenerative disorders
Samantha Roudi, Julia Rädler, Samir EL Andaloussi
Handbook of clinical neurology (2023), pp. 243-266
Closed Access | Times Cited: 8
Multifunctional bioreactive-nanoconstructs for sensitive and accurate MRI of cerebrospinal fluid pathology and intervention of Alzheimer’s disease
Chunsheng He, Taksim Ahmed, Azhar Z. Abbasi, et al.
Nano Today (2020) Vol. 35, pp. 100965-100965
Closed Access | Times Cited: 19
From Plaques to Pathways in Alzheimer’s Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis
Sarah Kazemeini, Ahmed Nadeem-Tariq, Ryan M. Shih, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11720-11720
Open Access | Times Cited: 2
Gastrointestinal Changes and Alzheimer's Disease
Mona Sohrabi, Bijayani Sahu, Harpreet Kaur, et al.
Current Alzheimer Research (2022) Vol. 19, Iss. 5, pp. 335-350
Open Access | Times Cited: 10
Sex Differences in Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer’s Disease Patients
Marta Sochocka, Michał Ochnik, Maciej Sobczyński, et al.
Archivum Immunologiae et Therapiae Experimentalis (2022) Vol. 70, Iss. 1
Closed Access | Times Cited: 8
TgF344-AD Rat Model of Alzheimer’s Disease: Spatial Disorientation and Asymmetry in Hemispheric Neurodegeneration
Boriss Sagalajev, Lina Lennartz, Lukas Vieth, et al.
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 1085-1094
Open Access | Times Cited: 4
β‐sheet breakers with consecutive phenylalanines: Insights into mechanism of dissolution of β‐amyloid fibrils
Adam Jarmuła, Jan Ludwiczak, Dariusz Stępkowski
Proteins Structure Function and Bioinformatics (2021) Vol. 89, Iss. 7, pp. 762-780
Closed Access | Times Cited: 7
Non-Communicable Neurological Disorders and Neuroinflammation
Clara Ballerini, Alfred K. Njamnshi, Sharon L. Juliano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer’s Disease Platform
Tatiana Karelina, Stepan Lerner, Alexander A. Stepanov, et al.
CPT Pharmacometrics & Systems Pharmacology (2021) Vol. 10, Iss. 6, pp. 543-550
Open Access | Times Cited: 6
Radioactive synthesis of tau PET imaging agent 18F-AV-1451 and its role in monitoring the progression of Alzheimer’s disease and supporting differential diagnosis
Wenyan Zhang, Shuoyan Xu, Hongmei Yu, et al.
Annals of Nuclear Medicine (2021) Vol. 35, Iss. 2, pp. 139-147
Closed Access | Times Cited: 5
Structural biology of cell surface receptors implicated in Alzheimer’s disease
S.J. Hermans, Tracy L. Nero, Craig J. Morton, et al.
Biophysical Reviews (2021) Vol. 14, Iss. 1, pp. 233-255
Open Access | Times Cited: 5
Neurodegenerative diseases: from gut-brain axis to brain microbiome
Robert P. Friedland, Bodduluri Haribabu
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 1
Therapeutic Potential of MCC950 in Restoring Autophagy and Cognitive Function in STZ-Induced Rat Model of Alzheimer's Disease
Abdul Naeem, Arshi Waseem, Mohsin Ali Khan, et al.
Molecular Neurobiology (2024)
Closed Access
The Amyloid Cascade Hypothesis Has to Deliver, Finally
Christian Behl
Springer eBooks (2023), pp. 309-350
Closed Access
TgF344-AD rat model of Alzheimer’s disease: spatial disorientation and asymmetry in hemispheric neurodegeneration
Boriss Sagalajev, Lina Lennartz, Lukas Vieth, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1 - Next Page

Scroll to top